Evidence map›Paper›PMID 20026096›Full record

ArticleToxicology and applied pharmacology2010

Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico.

Enrique Fuentes-Mattei, Evasomary Rivera, Adriana Gioda, Diana Sanchez-Rivera, Felix R Roman-Velazquez, Braulio D Jimenez-Velez

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. PMToxics · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Effects of Different Components of PMInternational journal of environmental research and public health · 2019
    Article
  13. The pollution characteristics of PMEnvironmental geochemistry and health · 2018
    Article
  14. Article
  15. Serum cytokine levels related to exposure to volatile organic compounds and PMInternational journal of chronic obstructive pulmonary disease · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Enrique Fuentes-MatteiDepartment of Biochemistry, School of Medicine, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico.
Evasomary Rivera
Adriana Gioda
Diana Sanchez-Rivera
Felix R Roman-Velazquez
Braulio D Jimenez-Velez
University of Puerto Rico, Medical Sciences Campus · PRUniversity of Puerto Rico-Mayaguez · PR

Funding

SUPPLEMENT FOR RENOVATION OF ANIMAL FACILITIES AT INSTITUTE OF NEUROBIOLOGYG12RR003051 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI RODRIGUEZ-MEDINA, JOSE R · 1986 to 2011
$28.1M
UPR--MEDICAL SCIENCES CAMPUS, MBRS PROGRAMS06GM008224 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SILVA, WALTER I · 1989 to 2008
$28.0M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
NCRR NIH HHS G12 RR003051NCRR NIH HHS G12RR03051NIGMS NIH HHS 2R25GM061838-09NIGMS NIH HHS 5R25GM061838-08NIGMS NIH HHS 5S06-GM008224NIGMS NIH HHS R25 GM061838NIGMS NIH HHS S06 GM008224
6 · The paper itself

Abstract

Fine particulate air pollutants, mainly their organic fraction, have been demonstrated to be associated with cardiovascular and respiratory health problems. Puerto Rico has been reported to have the highest prevalence of pulmonary diseases (e.g., asthma) in the United States. The aim of this study was to assess, for the first time, the immunological response of human bronchial epithelial cells (BEAS-2B) to organic extracts isolated from airborne particulate matter (PM(2.5)) in Puerto Rico. Organic extracts from PM(2.5) collected throughout an 8-month period (2000-2001) were pooled (composite) in order to perform chemical analysis and biological activity testing. BEAS-2B cells were exposed to PM(2.5) organic extract to assess cytotoxicity, levels of cytokines and relative gene expression of MHC-II, hPXR and CYP3A5. Our findings show that organic PM(2.5) consist of toxic as well as bioactive components that can regulate the secretion of cytokines in BEAS-2B, which could modulate inflammatory response in the lung. Trace element analyses confirmed the presence of metals in organic extracts highlighting the relative high abundance of Cu and Zn in polar organic extracts. Polar organic extracts exhibited dose-dependant toxicity and were found to significantly induce the release of interleukin 6 (IL-6), IL-1beta and IL-7 while significantly inhibiting the secretion of IL-8, G-CSF and MCP-1. Moreover, MHC-II transcriptional activity was up-regulated after 24 h of exposure, whereas PXR and CYP3A5 were down-regulated. This research provides a new insight into the effects of PM(2.5) organic fractions on specific effectors and their possible role in the development of respiratory inflammatory diseases in Puerto Rico.

Indexed as

Air Pollutants, OccupationalBiomarkersBronchiCell LineCytochrome P-450 CYP3ACytokinesEnvironmental MonitoringEpithelial CellsGenes, MHC Class IIHLA-DR2 AntigenHumansParticulate MatterPregnane X ReceptorPuerto RicoReceptors, SteroidReverse Transcriptase Polymerase Chain ReactionAir Pollutants, OccupationalBiomarkersCYP3A5 protein, humanCytochrome P-450 CYP3ACytokinesHLA-DR2 AntigenParticulate MatterPregnane X ReceptorReceptors, SteroidRNA, MessengerTrace Elements

Identifiers

PMID20026096
PMCPMC2925116
OpenAlexW2150553281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.